×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Chime Biologics Partners with Polpharma Biologics to Advance Global Biosimilar Development
Mediar Therapeutics launches a second clinical program targeting fibrosis with novel first-in-class antibodies
07 Aug 2024
Mediar Therapeutics, Inc., a clinical stage biotechnology company advancing a portfolio of
...
Neurotech Welcomes Industry Veteran Beth Marsh as Chief Commercial Officer
Kiromic BioPharma reports positive results from third patient in Deltacel-01 trial
IKA introduces new accessories for the HABITAT research bioreactor.
To Redefine Specialty Care, Craft Telemedicine Launches with a Human-Centered Platform
Ron Mayron Becomes Chairman of the Board of Matricelf Ltd
By
Matricelf Ltd.
Matricelf Ltd.
27 Feb 2026
ARUP Laboratories Establishes Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
By
ARUP Laboratories
ARUP Laboratories
26 Feb 2026
Neurizon Begins Dosing of NUZ-001 in HEALEY ALS Platform Trial
By
Neurizon Therapeutics Limited
Neurizon Therapeutics Limited
27 Feb 2026
Unique Mouse Model Enables genOway to Transform Prediction of Antibody Therapies in Humans
By
genOway
genOway
26 Feb 2026
CollPlant Expands Its rhCollagen 3D Bioprinting Portfolio Through the Launch of Ready-to-Print BioFlex
By
CollPlant
CollPlant
24 Feb 2026
With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology
By
Bruker Corporation
Bruker Corporation
24 Feb 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Enhancing Preclinical Research Support, SoBran, Inc. Expands BioScience Services to Los Angeles
By
SoBran, Inc.
Jun 18
Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America
By
Hanmi Pharmaceutical
Apr 02
LabConnect and Australian Clinical Labs' Specialised Trials Announce a Strategic Partnership in the Australia and Asia Pacific Region
By
LabConnect
Feb 23
March
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
